GlaxoSmithKline gsk.com

GlaxoSmithKline (NYSE: GSK) develops and markets pharmaceuticals, vaccines, over-the-counter medicines, and health care products.

GlaxoSmithKline (NYSE: GSK) develops and markets pharmaceuticals, vaccines, over-the-counter medicines, and health care products.

See All Exits Recent Exits

Phone: +44 (0)20 8047 5000

Fax:

980 Great West Road
Brentford
 Middlesex, TW8 9GS
 England, United Kingdom

GlaxoSmithKline - Investments & Acquisitions

Show Real Data GlaxoSmithKline Investments
See all Recent Investments
Date Company Round Amount Co-investors
2020-04-06Vir BiotechnologyCorporate Minority - P2P$250M
2019-09-11Sitari PharmaceuticalsAcquired
2019-04-01SpringWorks TherapeuticsSeries B$125MArrowMark Partners, Bain Capital, Boxer Capital, BVF Partners, HBM Healthcare Investments, Laurion Capital Management, LifeArc, OrbiMed Advisors, Perceptive Advisors, Samsara BioCapital, and Surveyor Capital
2018-12-19GlaxoSmithKline & Pfizer Consumer HealthCorporate Majority
2018-12-03TesaroAcq - P2P
See all 5 investments